The authors reply
- PMID: 39418008
- DOI: 10.1097/CCM.0000000000006412
The authors reply
Conflict of interest statement
Dr. Gessler received funding from B. Braun Aesculap, Signus Consulting, and AstraZeneca. Dr. Strzelczyk received funding from Angelini Pharma, Bicodex, Desitin, Eisai, Jazz, Takeda, Union Chimique Belge, and UNEEG Medical. The remaining authors have disclosed that they do not have any potential conflicts of interest.
References
-
- Pease M, Gonzalez-Martinez J, Puccio A, et al.: Risk factors and incidence of epilepsy after severe traumatic brain injury. Ann Neurol 2022; 92:663–669
-
- Won S-Y, Konczalla J, Dubinski D, et al.: A systematic review of epileptic seizures in adults with subdural haematomas. Seizure 2017; 45:28–35
-
- Won S-Y, Dubinski D, Herrmann E, et al.: Epileptic seizures in patients following surgical treatment of acute subdural hematoma-incidence, risk factors, patient outcome, and development of new scoring system for prophylactic antiepileptic treatment (GATE-24 score). World Neurosurg 2017; 101:416–424
-
- Won S-Y, Freiman TM, Lee-Müller SS, et al.: The long-term use of diagnostic subdural electroencephalogram electrodes and subdural hematoma: A prospective cohort study. Crit Care Med 2023; 51:1754–1765
-
- Wu L, Gao G: Subdural electroencephalogram monitoring for early seizure detection in patients with subdural hematoma: Considering it in the real world. Crit Care Med 2024; 52:e589–e590
LinkOut - more resources
Full Text Sources